ALERT: Fake Drug Series Report Received from AATA

The Health and Labor Inspection Body of Armenia warns citizens that there has been a case of counterfeiting in the Swiss drug "Perjeta" series No. 7796, and it is advised to refrain from using it.

According to letter No. 01/2457-26 received on May 11, 2026, from the State Expert Center for Medicines and Medical Technologies, Hoffmann-La Roche AG provided information regarding the counterfeiting of the drug Perjeta (pertuzumab) concentrate for solution for intravenous administration, 30 mg/ml, glass vial 14 ml (registration certificate holder: F. Hoffmann-La Roche Ltd, Switzerland) series No. 7796.

Dear citizens, please be attentive and avoid using the drug of series No. 7796.